Should you buy, hold, or sell CBA, CSL, and Pilbara Minerals shares?

Let's see what analysts are saying about these big names.

| More on:
Middle age caucasian man smiling confident drinking coffee at home.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

There are 200 shares for investors to choose from on the ASX 200 index.

To narrow things down for investors, let's take a look at three very popular shares that Fairmont Equities has given its verdict on, courtesy of The Bull.

Here's what it is saying about these giants:

Commonwealth Bank of Australia (ASX: CBA)

Fairmont Equities was bullish on Australia's largest bank last year and benefited from its record-breaking rally.

However, with its shares looking expensive and its share price chart showing signs of weakness, it feels that now is the time to sell. It explains:

We turned bullish on CBA in early 2024 as it broke above a major resistance level and started to rally. We remained bullish until recently when the share price chart finally showed signs of weakness. This also coincides with long held investor concerns around CBA's valuation. While we didn't sell CBA on valuation grounds and rode it higher in the past 18 months, a topping signal on the chart is a sign to finally exit this position, in our view.

CSL Ltd (ASX: CSL)

Another ASX 200 share that Fairmont Equities has been looking at is biotherapeutics giant CSL.

Its analysts note that the company's shares have been recovering in recent months. And while they have stopped short of calling it a buy, they think it would be one to hold tightly to for the future. They explain:

This global biotechnology giant provides medicines to patients in more than 100 countries. The company makes vaccines to prevent influenza. Its medicines treat haemophilia and immune deficiencies, and it offers therapies in iron deficiency and nephrology. The share price is starting to recover from its lows in response to mixed first half results in fiscal year 2025 and uncertainty surrounding US tariffs. The shares have risen from $234.34 on June 27 to trade at $271.56 on July 31. We view CSL as a solid hold for capital growth and income.

Pilbara Minerals Ltd (ASX: PLS)

Finally, Fairmont Equities has been looking at lithium giant Pilbara Minerals.

Its analysts are optimistic that a recovery could be on the cards for its shares. However, they are not confident enough to call it a buy just yet and instead rate Pilbara Minerals as a hold. They said:

Most lithium miners have rallied well in the past few weeks and there are signs the sector is at or near the bottom. Like most lithium miners, PLS had been trending lower for the past two years, but it recently reached a new peak on the share price chart by breaking above the May high on good volume. It's early days, but this could be the first step in PLS breaking the downtrend and embarking on a likely recovery.

Motley Fool contributor James Mickleboro has positions in CSL. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A man looking at his laptop and thinking.
Broker Notes

Forget Newmont and buy these ASX 200 shares

Let's see what analysts are recommending this week.

Read more »

St Barbara share price Minder underground looks excited a he holds a nugget of gold he has discovered.
Broker Notes

This ASX All Ords gold stock is tipped to rocket 182%! Here's why

A leading broker forecasts outsized gains from this up-and-coming ASX All Ords gold stock.

Read more »

A woman reaches her arms to the sky as a plane flies overhead at sunset.
Broker Notes

How high can Qantas shares fly? This prediction might surprise you

The team at Jarden have updated their outlook for Qantas shares following a recent trading update.

Read more »

a family stands together behind a sold sign with their new house in the background.
Broker Notes

Where to from here for REA Group shares?

The competitive threats to REA Group are mounting, the team at Macquarie says.

Read more »

A toy house sits on a pile of Australian $100 notes.
Broker Notes

Macquarie says this 'key pick' in the real estate sector can deliver strong double-digit gains

This real estate-exposed company can deliver solid shareholder returns.

Read more »

Person holding up a smartphone in front of a stock market chart.
Broker Notes

Macquarie upgrades this ASX 200 stock to 'outperform'; tips 16% upside

Trading volumes are rising, competition is easing, and valuation looks attractive.

Read more »

Portrait of a female student on graduation day from university.
Broker Notes

Down 60% this year, does Macquarie think IDP Education shares can turnaround?

The stock has been crushed, but one major broker thinks the worst may be behind it.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Morgans names 3 ASX 200 shares to buy in November

Let's see which shares the broker is bullish on right now.

Read more »